×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Merck to Buy Verona Pharma in $10 Billion Deal
The Wall Street Journal
Merck & Co. has struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive pulmonary disease...
3 days ago
Merck Snags A $10 Billion Buyout
Investor's Business Daily
Merck said Wednesday it would buy COPD drugmaker Verona Pharma for $10 billion. The news sent Verona stock flying.
3 days ago
Top Analyst Reports for Microsoft, Alibaba & Merck
Yahoo Finance
MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.
1 day ago
Key deals this week: Meta, Boyd Gaming, Merck, Sandstorm Gold, Capgemini and more
Seeking Alpha
Discover major market movements with this week's top acquisition deals across sectors, from Meta's AI expansion to Merck's $10B Verona...
4 hours ago
Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre
Fierce Pharma
Merck has agreed to a $10-billion buyout of Verona Pharma and its first-in-class, potential COPD blockbuster Ohtuvayre.
3 days ago
Merck buys Raleigh drugmaker for $10 billion, drawn by new COPD treatment
Raleigh News & Observer
In one of the biggest health care deals of 2025, the pharmaceutical giant Merck has acquired the British drugmaker Verona Pharma for roughly...
3 days ago
Merck to buy Verona and its lung drug in $10B deal
BioPharma Dive
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
3 days ago
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
BioSpace
In the second biggest acquisition of the year, Merck gains the commercial COPD drug Ohtuvayre, which could help offset the loss of revenue...
3 days ago
Merck acquires Raleigh pharma for $10 billion
The Business Journals
Merck acquires Verona Pharma for $10B, gaining Ohtuvayre, a breakthrough COPD treatment with rapid uptake since its 2024 launch.
3 days ago
Merck will have 'a lot more work to do' after Verona deal
Yahoo Finance
Merck (MRK) is spending about $10 billion to acquire Verona Pharma (VRNA) as the company looks to fill future revenue gaps.
3 days ago